Category Archives: TB

UN General Assembly recognizes antimicrobial resistance as global public health threat

By on .

Declaration flags resistance to antibiotics, including for TB treatment, as “greatest and most urgent global risk” Emphasizing imperatives to strengthen local health surveillance and service capacities worldwide, for biomedical research and development driven by evidence and needs, and for collaborations between human health, veterinary, and environmentally related disciplines, the member nations of the United Nations […]

Underfunded tuberculosis programs often solely responsible for TB-HIV activities, report finds

By on .

While tuberculosis remains the number one killer of people living with HIV – with one in three HIV-related deaths attributable to tuberculosis – the burden to provide TB-HIV integrated services falls heavily on tuberculosis programs, not HIV programs, a report from Action finds. The report, “From Policy to Practice: How the TB-HIV response is working,” […]

Multi-country survey sheds light on drug-resistant tuberculosis treatment needs

By on .

Findings highlight gaps in available testing, regimens The first survey to assess tuberculosis that does not respond to common treatments across populations in multiple high-disease-burden countries shows a need for better understanding of the dynamics of drug-resistant disease, including through tests that do not yet exist. The survey’s findings, detailed in The Lancet Infectious Diseases, […]

“Test and treat” is the ideal — but in TB and other illnesses, “guess and treat” is the more common reality

By on .

Science Speaks staff writer and Global Health Policy Research Coordinator Rabita Aziz attended the McGill University Summer Institute in Infectious Diseases and Global Health June 13-17. MONTREAL – In health care, “test and treat” is considered the ideal. It’s a term most familiar to followers of HIV responses, in which treatment follows, rather than precedes, diagnostic […]

The forgotten killer, a need for shorter, better treatment, a measure of failures to diagnose children, and the impacts of inequity . . . We’re reading about tuberculosis

By on .

Energizing the fight against HIV/AIDS in South Africa – A  history of inequality, a government’s long refusal to acknowledge the virus, a donor relationship in perpetual transition . . . these are among the challenges to controlling HIV in this epicenter of the pandemic. But, this report notes, one of the biggest challenges to success […]

Wanted: Continued development of TB diagnostics to reduce antimicrobial resistance

By on .

Science Speaks staff writer and Global Health Policy Research Coordinator Rabita Aziz is attending and writing from McGill Summer Institute in Infectious Diseases and Global Health this week. MONTREAL — New diagnostic technology for tuberculosis still is needed not only for TB control, but to combat growing antimicrobial resistance, Dr. Madhukar Pai said here this […]

HLM 2016 AIDS: TB gets time and targets, as leaders weigh impacts of No. 1 killer

By on .

NEW YORK – At a “high-level” meeting of nations all confronting the impacts of a still incurable virus, it may seem strange that just one event and a scattering of mentions in a political declaration have been dedicated to the leading — and curable — killer of people with that virus. But for leaders of responses to tuberculosis […]

TB Elimination: India can Lead the Way

By on .

As the United Nations High Level Meeting on HIV/AIDS gets underway today in New York, Indian Prime Minister Narendra Modi is meeting with Congress this week. Tuberculosis advocates are hoping to see Prime Minister Modi and members of Congress renew their commitment to eliminating TB in India, which has one of the highest TB burdens […]

Addressing development of tuberculosis diagnostics and drugs is critical to global antimicrobial resistance response, review finds

By on .

A new tool to diagnose drug-resistant tuberculosis with an improved regimen to then treat it would more than halve the current death toll from the disease within six years, saving 100,000 lives annually, according to a report commissioned by the British government. The report brings the findings and recommendations of the Review on Antimicrobial Resistance, […]

WHO recommendations aim to speed diagnosis, treatment of MDR-TB

By on .

The two years of toxic medicines that make up the common course of treatment for drug-resistant tuberculosis is so grueling and discouraging, as one Médecins Sans Frontières physician put it, that it causes “teenagers to abandon their ambitions, adults to decide between providing for their family or getting healthy and the elderly to wish for […]